BG105998A - Treatment of certain cancers associated with weight gain - Google Patents

Treatment of certain cancers associated with weight gain

Info

Publication number
BG105998A
BG105998A BG105998A BG10599801A BG105998A BG 105998 A BG105998 A BG 105998A BG 105998 A BG105998 A BG 105998A BG 10599801 A BG10599801 A BG 10599801A BG 105998 A BG105998 A BG 105998A
Authority
BG
Bulgaria
Prior art keywords
cancers associated
treatment
weight gain
certain cancers
cancer
Prior art date
Application number
BG105998A
Other languages
Bulgarian (bg)
English (en)
Inventor
Carl Mendel
Timothy SEATON
Steve Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BG105998A publication Critical patent/BG105998A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG105998A 1999-03-19 2001-10-10 Treatment of certain cancers associated with weight gain BG105998A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19
PCT/US2000/007361 WO2000056323A1 (en) 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain

Publications (1)

Publication Number Publication Date
BG105998A true BG105998A (en) 2002-06-28

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105998A BG105998A (en) 1999-03-19 2001-10-10 Treatment of certain cancers associated with weight gain

Country Status (19)

Country Link
EP (1) EP1171106A1 (no)
JP (1) JP2002539255A (no)
KR (1) KR20010113765A (no)
CN (1) CN1399545A (no)
AU (1) AU3632000A (no)
BG (1) BG105998A (no)
BR (1) BR0009161A (no)
CA (1) CA2367045A1 (no)
CZ (1) CZ20013281A3 (no)
HU (1) HUP0200497A2 (no)
IL (1) IL145239A0 (no)
MX (1) MXPA01009470A (no)
NO (1) NO20014478L (no)
NZ (1) NZ514012A (no)
PL (1) PL351958A1 (no)
SK (1) SK13372001A3 (no)
TR (1) TR200102692T2 (no)
WO (1) WO2000056323A1 (no)
ZA (1) ZA200107687B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
JP2002539255A (ja) 2002-11-19
IL145239A0 (en) 2002-06-30
CN1399545A (zh) 2003-02-26
BR0009161A (pt) 2002-01-22
PL351958A1 (en) 2003-07-14
TR200102692T2 (tr) 2002-03-21
NO20014478D0 (no) 2001-09-14
HUP0200497A2 (en) 2002-08-28
MXPA01009470A (es) 2004-03-19
NZ514012A (en) 2001-09-28
CZ20013281A3 (cs) 2002-07-17
AU3632000A (en) 2000-10-09
NO20014478L (no) 2001-10-29
CA2367045A1 (en) 2000-09-28
SK13372001A3 (sk) 2002-07-02
KR20010113765A (ko) 2001-12-28
WO2000056323A1 (en) 2000-09-28
ZA200107687B (en) 2002-12-18
EP1171106A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
MXPA01009404A (es) Metodo para tratar trastornos de alimentacion.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
GB0125259D0 (en) Novel compounds
PL1653947T3 (pl) Pochodne oksymów (4-hydroksyfenylo)-1H-indolo-3-karbaldehydów jako środki estrogenne
GB0225475D0 (en) Therapeutic agents
PL367682A1 (en) Dolastatin 10 derivatives
MXPA05009668A (es) Proceso libre de azida para preparar compuestos de 1,2-diamino.
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
IL137964A0 (en) Antitumor agents
WO2000056315A8 (en) Treatment of pain
TW200508199A (en) Novel compound
BG105998A (en) Treatment of certain cancers associated with weight gain
BG105999A (en) Treatment of osteoarthritis
MXPA01009469A (es) Tratamiento para disminuir la adhesividad de las plaquetas.
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
BG106000A (en) Treatment of hiatial hernia
MXPA01009462A (es) Tratamiento de calculos biliares.
MXPA01009465A (es) Perdida de peso despues del embarazo.
BG105996A (en) Method of treating eating disorders
JO2301B1 (en) Method for the preparation of stabilizer Neuraminides R-OH-64-796